These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex. Rothman RB, Bykov V, Mahboubi A, Long JB, Jiang Q, Porreca F, de Costa BR, Jacobson AE, Rice KC, Holaday JW. Synapse; 1991 Jun 29; 8(2):86-99. PubMed ID: 1652797 [Abstract] [Full Text] [Related]
10. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. Mansour A, Lewis ME, Khachaturian H, Akil H, Watson SJ. Brain Res; 1986 Dec 03; 399(1):69-79. PubMed ID: 3026574 [Abstract] [Full Text] [Related]
11. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Portoghese PS, Sultana M, Takemori AE. Eur J Pharmacol; 1988 Jan 27; 146(1):185-6. PubMed ID: 2832195 [No Abstract] [Full Text] [Related]
12. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. De Souza EB, Schmidt WK, Kuhar MJ. J Pharmacol Exp Ther; 1988 Jan 27; 244(1):391-402. PubMed ID: 2826773 [Abstract] [Full Text] [Related]
13. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M, Sagan S, Mor A, Pelaprat D, Rostene W, Delfour A, Nicolas P. Eur J Biochem; 1990 May 20; 189(3):625-35. PubMed ID: 2161761 [Abstract] [Full Text] [Related]
14. Characterisation of opioid binding sites using selective antagonists. Lawrence AJ, Traynor JR. Prog Clin Biol Res; 1990 May 20; 328():121-4. PubMed ID: 1968257 [No Abstract] [Full Text] [Related]
15. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. Negri L, Lattanzi R, Borsodi A, Toth G, Salvadori S. Antisense Nucleic Acid Drug Dev; 1999 Apr 20; 9(2):203-11. PubMed ID: 10355826 [Abstract] [Full Text] [Related]
16. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Kathmann M, Flau K, Redmer A, Tränkle C, Schlicker E. Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb 20; 372(5):354-61. PubMed ID: 16489449 [Abstract] [Full Text] [Related]
18. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Crook TJ, Kitchen I, Hill RG. Br J Pharmacol; 1992 Oct 20; 107(2):573-6. PubMed ID: 1330187 [Abstract] [Full Text] [Related]
19. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone. Bhargava HN, Das S. Brain Res; 1986 Mar 19; 368(2):262-7. PubMed ID: 3008927 [Abstract] [Full Text] [Related]
20. In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain. Lever JR, Scheffel U, Kinter CM, Ravert HT, Dannals RF, Wagner HN, Frost JJ. Eur J Pharmacol; 1992 Jun 17; 216(3):459-60. PubMed ID: 1330587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]